Application

S SEBELA PHARMACEUTICALS

Sebela Ireland Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88819213
Filing Date: 03/03/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88819213
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\888\192\88819213\xml1\ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT SEBELA PHARMACEUTICALS
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) grey and turquoise is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the stylized wording "SEBELA" in turquoise above the word "PHARMACEUTICALS" in grey, appearing to the right of a stylized reverse letter "S" with a horizontal line and three dots all in grey.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 966 x 403
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Sebela Ireland Limited
INTERNAL ADDRESS 3rd Floor, West Wing, Adelaide Chambers
*MAILING ADDRESS Peter Street
*CITY Dublin
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
8
*EMAIL ADDRESS tm@gbpatent.com
LEGAL ENTITY INFORMATION
TYPE company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders; Pharmaceutical and medicated preparations, namely, for use in the treatment of pain and inflammation; Pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical and medicated preparations for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical product
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER FIIE202000000113663
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
       FOREIGN FILING DATE 02/26/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Jeffrey H. Handelsman
ATTORNEY DOCKET NUMBER T59044
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Greenblum & Bernstein, P.L.C.
STREET 1950 Roland Clarke Place
CITY Reston
STATE Virginia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20191-1411
PHONE 703-716-1191
FAX 703-716-1180
EMAIL ADDRESS eteas@gbpatent.com
OTHER APPOINTED ATTORNEY Neil F. Greenblum; Bruce H. Bernstein; William S. Boshnick; Jill M. Browning
DOMESTIC REPRESENTATIVE INFORMATION
NAME Jeffrey H. Handelsman
FIRM NAME Greenblum & Bernstein, P.L.C.
STREET 1950 Roland Clarke Place
CITY Reston
STATE Virginia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 20191-1411
PHONE 703-716-1191
FAX 703-716-1180
EMAIL ADDRESS eteas@gbpatent.com
CORRESPONDENCE INFORMATION
NAME Jeffrey H. Handelsman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE eteas@gbpatent.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Jeffrey H. Handelsman/
SIGNATORY'S NAME Handelsman, Jeffrey H.
SIGNATORY'S POSITION Attorney for Applicant, MD Bar (Ref.: T59044)
SIGNATORY'S PHONE NUMBER 703-716-1191
DATE SIGNED 03/03/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88819213
Filing Date: 03/03/020

To the Commissioner for Trademarks:

MARK: SEBELA PHARMACEUTICALS (stylized and/or with design, see mark)
The literal element of the mark consists of SEBELA PHARMACEUTICALS. The color(s) grey and turquoise is/are claimed as a feature of the mark. The mark consists of the stylized wording "SEBELA" in turquoise above the word "PHARMACEUTICALS" in grey, appearing to the right of a stylized reverse letter "S" with a horizontal line and three dots all in grey.
The applicant, Sebela Ireland Limited, a company organized under the laws of Ireland, having an address of
      3rd Floor, West Wing, Adelaide Chambers
      Peter Street
      Dublin 8
      Ireland
      tm@gbpatent.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders; Pharmaceutical and medicated preparations, namely, for use in the treatment of pain and inflammation; Pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical and medicated preparations for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical product
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Ireland application number FIIE202000000113663, filed 02/26/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.





The owner's/holder's proposed attorney information: Jeffrey H. Handelsman. Other appointed attorneys are Neil F. Greenblum; Bruce H. Bernstein; William S. Boshnick; Jill M. Browning. Jeffrey H. Handelsman of Greenblum & Bernstein, P.L.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1950 Roland Clarke Place
      Reston, Virginia 20191-1411
      United States
      703-716-1191(phone)
      703-716-1180(fax)
      eteas@gbpatent.com
The docket/reference number is T59044.
Jeffrey H. Handelsman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Jeffrey H. Handelsman of Greenblum & Bernstein, P.L.C.
      1950 Roland Clarke Place
      Reston Virginia 20191-1411
      United States
      703-716-1191(phone)
      703-716-1180(fax)
      eteas@gbpatent.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.


The applicant's current Correspondence Information:
      Jeffrey H. Handelsman
       PRIMARY EMAIL FOR CORRESPONDENCE: eteas@gbpatent.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Jeffrey H. Handelsman/   Date: 03/03/2020
Signatory's Name: Handelsman, Jeffrey H.
Signatory's Position: Attorney for Applicant, MD Bar (Ref.: T59044)
Payment Sale Number: 88819213
Payment Accounting Date: 03/03/2020

Serial Number: 88819213
Internet Transmission Date: Tue Mar 03 16:18:14 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20200303161814
115081-88819213-7109144bacc18604fe7c8d5a
9b216287481b3ff3667fa8795869ce28fb8e9ef7
b69-CC-18127966-20200303161353402123

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed